Arecor Therapeutics plc

Arecor Therapeutics plcverified

AREC.L

Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headqua...[Read more]

Industry

Biotechnology

IPO Date

2021-06-03

Stock Exchange

LSE

Ticker

AREC.L

The ROE as of December 2025 (TTM) for Arecor Therapeutics plc (AREC.L) is -197.54%

According to Arecor Therapeutics plc’s latest financial reports and current stock price. The company's current ROE is -197.54%. This represents a change of 142.33% compared to the average of -81.52% of the last 4 quarters.

Arecor Therapeutics plc (AREC.L) Historical ROE (quarterly & annually)

How has AREC.L ROE performed in the past?

The mean historical ROE of Arecor Therapeutics plc over the last ten years is -112.91%. The current -197.54% ROE has changed 74.96% with respect to the historical average. Over the past ten years (40 quarters), AREC.L's ROE was at its highest in in the May 2017 quarter at 0%. The ROE was at its lowest in in the December 2020 quarter at -220.37%.

Quarterly (TTM)
Annual

Average

-112.91%

Median

-68.25%

Minimum

-355.70%

Maximum

0%

Arecor Therapeutics plc (AREC.L) ROE by Quarter and Year

Discovering the peaks and valleys of Arecor Therapeutics plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 421.14%

Maximum Annual ROE = 0%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -355.70%

Quarterly (TTM)
Annual
YearROEChange
2024-191.36%113.13%
2023-89.79%69.25%
2022-53.05%59.51%
2021-33.26%-90.65%
2020-355.70%421.14%
2019-68.25%18.16%
2019-57.77%-65.40%
2018-166.97%-Infinity%

Arecor Therapeutics plc (AREC.L) Average ROE

How has AREC.L ROE performed in the past?

The current ROE of Arecor Therapeutics plc (AREC.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-111.40%

5-year avg

-144.63%

10-year avg

-112.91%

Arecor Therapeutics plc (AREC.L) ROE vs. Peers

How is AREC.L’s ROE compared to its peers?

Arecor Therapeutics plc’s ROE is greater than Poolbeg Pharma PLC (-53.86%), greater than Novacyt S.A. (-25.68%), greater than Aptamer Group plc (-131.23%), greater than Sareum Holdings plc (-134.34%), less than Renalytix Plc (123.11%), greater than Hemogenyx Pharmaceuticals Plc (-141.83%), greater than Fusion Antibodies plc (-210.32%), greater than Genflow Biosciences plc (-105.34%), greater than OptiBiotix Health Plc (-2.27%), greater than IXICO plc (-14.21%),

Build a custom stock screener for Arecor Therapeutics plc (AREC.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arecor Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arecor Therapeutics plc (AREC.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arecor Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Arecor Therapeutics plc's ROE?

How is the ROE calculated for Arecor Therapeutics plc (AREC.L)?

What is the highest ROE for Arecor Therapeutics plc (AREC.L)?

What is the 3-year average ROE for Arecor Therapeutics plc (AREC.L)?

What is the 5-year average ROE for Arecor Therapeutics plc (AREC.L)?

How does the current ROE for Arecor Therapeutics plc (AREC.L) compare to its historical average?